CANDESARTAN CILEXETIL TABLET

Страна: Канада

Език: английски

Източник: Health Canada

Активна съставка:

CANDESARTAN CILEXETIL

Предлага се от:

ALEMBIC PHARMACEUTICALS LIMITED

АТС код:

C09CA06

INN (Международно Name):

CANDESARTAN

дозиране:

32MG

Лекарствена форма:

TABLET

Композиция:

CANDESARTAN CILEXETIL 32MG

Начин на приложение:

ORAL

Броя в опаковка:

30/100/1000

Вид предписание :

Prescription

Терапевтична област:

ANGIOTENSIN II RECEPTOR ANTAGONISTS

Каталог на резюме:

Active ingredient group (AIG) number: 0135220004; AHFS:

Статус Оторизация:

APPROVED

Дата Оторизация:

2014-04-25

Данни за продукта

______________________________________________________________________________
_Candesartan Cilexetil Product Monograph_
_ Page 1 of 39_
PRODUCT MONOGRAPH
PR
CANDESARTAN CILEXETIL
Candesartan Cilexetil Tablets
4 mg, 8 mg, 16 mg and 32 mg
Angiotensin II AT
1
Receptor Blocker
MANUFACTURED BY:
Alembic Pharmaceuticals Limited, DATE OF PREPARATION:
Alembic Road, Vadodara 390003,
March 18, 2022
Gujarat, India.
IMPORTED AND DISTRIBUTED BY:
Alembic Pharmaceuticals Canada Ltd.
225 Gibraltar Road, Unit 5
Vaughan, Ontario
L4H 4P9, Canada
Submission
Control Numbers: 257724
______________________________________________________________________________
_Candesartan Cilexetil Product Monograph_
_ Page 2 of 39_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION...............................................................3
SUMMARY PRODUCT
INFORMATION...........................................................................3
INDICATIONS AND CLINICAL
USE.................................................................................3
CONTRAINDICATIONS......................................................................................................4
WARNINGS AND PRECAUTIONS
....................................................................................5
ADVERSE
REACTIONS.......................................................................................................9
DRUG
INTERACTIONS.....................................................................................................15
DOSAGE AND ADMINISTRATION
................................................................................19
OVERDOSAGE...................................................................................................................22
ACTION AND CLINICAL
PHARMACOLOGY...............................................................22
STORAGE AND
STABILITY.............................................................................................24
DOSAGE FORMS, COMPOSITION AND PACKAGING
.......................................